Acadia Healthcare (NASDAQ:ACHC) Receives Outperform Rating from Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a report published on Wednesday, MarketBeat.com reports. Royal Bank of Canada currently has a $94.00 price target on the stock.

Other research analysts have also recently issued research reports about the company. Cantor Fitzgerald reiterated a neutral rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, March 5th. UBS Group lifted their target price on Acadia Healthcare from $88.00 to $102.00 and gave the company a buy rating in a research report on Wednesday, February 28th. Mizuho decreased their target price on Acadia Healthcare from $84.00 to $70.00 and set a neutral rating on the stock in a research report on Friday, May 3rd. Bank of America reduced their price target on Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a report on Thursday, May 2nd. Finally, StockNews.com cut Acadia Healthcare from a hold rating to a sell rating in a report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare presently has an average rating of Moderate Buy and an average price target of $87.56.

Acadia Healthcare Stock Up 1.4 %

Shares of NASDAQ ACHC opened at $66.27 on Wednesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. Acadia Healthcare has a 52 week low of $64.11 and a 52 week high of $87.77. The stock has a market capitalization of $6.15 billion, a P/E ratio of -473.32, a PEG ratio of 1.99 and a beta of 1.31. The stock’s fifty day moving average is $72.83 and its 200 day moving average is $76.98.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same quarter in the previous year, the business posted $0.75 earnings per share. The business’s revenue for the quarter was up 9.1% on a year-over-year basis. Sell-side analysts forecast that Acadia Healthcare will post 3.53 earnings per share for the current fiscal year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.00% of the stock is currently owned by company insiders.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in ACHC. Iron Triangle Partners LP boosted its holdings in shares of Acadia Healthcare by 14.0% during the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock worth $71,521,000 after buying an additional 110,820 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Acadia Healthcare by 2.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,093 shares of the company’s stock worth $10,545,000 after buying an additional 2,584 shares in the last quarter. MQS Management LLC bought a new position in shares of Acadia Healthcare during the 1st quarter worth approximately $322,000. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Acadia Healthcare by 14.7% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 58,505 shares of the company’s stock worth $4,637,000 after buying an additional 7,491 shares in the last quarter. Finally, Clearbridge Investments LLC boosted its holdings in shares of Acadia Healthcare by 2.3% during the 1st quarter. Clearbridge Investments LLC now owns 202,550 shares of the company’s stock worth $16,046,000 after buying an additional 4,492 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.